Search results
J&J profit edges past Street view after deals delay Stelara competition
Reuters via Yahoo Finance· 3 months agoJohnson & Johnson on Tuesday reported quarterly results just above Wall Street expectations, helped...
Are your prescription drugs affordable? Colorado board wants feedback on these 2
KDVR Denver via Yahoo News· 2 weeks agoDENVER (KDVR) — A Colorado board continues reviewing the cost of prescription drugs, and public...
Medicare will negotiate drug prices with Big Pharma for the first time. Here’s how your prescription...
Fortune via Yahoo Finance· 6 months agoThe Inflation Reduction Act will let Medicare negotiate prescription drug prices with manufacturers...
J&J issues cautious 2023 forecast, shares fall
Reuters via Yahoo Finance· 1 year agoJohnson & Johnson on Tuesday cautioned investors over the lingering impact of inflation-driven costs this year as the healthcare conglomerate issued a...
It’s time for facts in the PBM debate
Fortune via Yahoo Finance· 4 weeks agoHealth care is complex, and so is the pharmacy landscape. That leads to a lot of lazy takes by people who mean well but don’t necessarily understand how...
Novartis' Sandoz targets biosimilar version of J&J drug in Samsung deal
Reuters via AOL· 8 months agoFRANKFURT (Reuters) -Novartis' generic-drugs unit Sandoz said on Monday it plans to launch a generic...
Unexpected drugs make first round of Medicare negotiations
The Hill via Yahoo News· 8 months agoThe Centers for Medicare and Medicaid Services (CMS) have officially named the first 10 drugs chosen...
J&J (JNJ) to Initiate Q1 Earnings Season for Pharma Sector
Zacks via Yahoo Finance· 1 year agoGrowth in J&J's (JNJ) Pharma unit is expected to have been driven by drugs like Darzalex and...
Medicare now negotiating price of drug that costs $7,100 in US vs. $900 in Canada
CNN via Yahoo News· 3 months agoSen. Bernie Sanders is once again taking the pharmaceutical industry to task, issuing a report...
Pharma CEOs, pressed by Senate panel, refuse to commit to price cuts
BioPharma Dive via Yahoo Finance· 3 months agoThe CEOs of three major drugmakers defended the prices they charge U.S. patients in a Senate...
